Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study
Multiple lines of evidence suggest that dysfunction of the metabotropic glutamate receptor subtype 5 (mGluR<sub>5</sub>) plays a role in the pathogenesis of autism spectrum disorder (ASD). Yet animal and human investigations of mGluR<sub>5 </sub>expression provide conflicting...
Main Authors: | James Robert Brašić, Ayon Nandi, David S. Russell, Danna Jennings, Olivier Barret, Samuel D. Martin, Keith Slifer, Thomas Sedlak, John P. Seibyl, Dean F. Wong, Dejan B. Budimirovic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/6/2863 |
Similar Items
-
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome
by: James R. Brašić, et al.
Published: (2020-11-01) -
Fragile X Syndrome in Mentally Retarded Patients from Latvia
by: Daneberga Zanda, et al.
Published: (2009-01-01) -
Arbaclofen in fragile X syndrome: results of phase 3 trials
by: Elizabeth Berry-Kravis, et al.
Published: (2017-06-01) -
Síndrome frágil X Fragile X Syndrome
Published: (2007-03-01) -
The fragile X syndrome: 13 years of experience
by: Daneberga Zanda, et al.
Published: (2011-01-01)